{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:27:40Z","timestamp":1789540060157,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2014\/13\/B\/NZ7\/02237"],"award-info":[{"award-number":["2014\/13\/B\/NZ7\/02237"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical University of \u0141\u00f3d\u017a, \u0141\u00f3d\u017a, Poland","award":["503\/3-011-01\/503-31-002"],"award-info":[{"award-number":["503\/3-011-01\/503-31-002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.neuro.2019.02.015","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T09:32:18Z","timestamp":1550914338000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["An expanding world of new psychoactive substances\u2014designer benzodiazepines"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-2389","authenticated-orcid":false,"given":"Jolanta B.","family":"Zawilska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9903-7206","authenticated-orcid":false,"given":"Jakub","family":"Wojcieszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuro.2019.02.015_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","article-title":"Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances \u2013 benzodiazepines diclazepam, flubromazepam, and pyrazolam \u2013 in the UK","volume":"14","author":"Abouchedid","year":"2018","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0010","series-title":"Circular 008\/2017: a Change to the Misuse of Drugs Act 1971 to Control U-47,700, Twelve Methylphenidate Related Substances and Sixteen \u2018designer\u2019 Benzodiazepines","author":"Advice Council on Misuse of Drugs","year":"2017"},{"key":"10.1016\/j.neuro.2019.02.015_bib0015","series-title":"Phenazepam Advice","author":"Advisory Council on the Misuse of Drugs","year":"2011"},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psym.2014.05.018","article-title":"Delirium induced by a new synthetic legal intoxicating drug: phenazepam","volume":"56","author":"Ali","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuro.2019.02.015_bib0025","article-title":"Detection of the designer benzodiazepine flunitrazolam in urine and preliminary data on its metabolism","author":"Ameline","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1455072517706304","article-title":"The slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum","volume":"34","author":"Anderson","year":"2017","journal-title":"Nordic Studies Alc. Drugs"},{"issue":"10","key":"10.1016\/j.neuro.2019.02.015_bib0035","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neuro.2019.02.015_bib0040","article-title":"Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project","author":"B\u00e4ckberg","year":"2018","journal-title":"Clin. Toxicol. Phila. (Phila)"},{"issue":"8","key":"10.1016\/j.neuro.2019.02.015_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jat\/34.8.527","article-title":"Fatality involving the ingestion of phenazepam and poppy seed tea","volume":"34","author":"Bailey","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajp.2018.07.019","article-title":"Etizolam withdrawal catatonia: the first case report","volume":"37","author":"Benerjee","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.neuro.2019.02.015_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224995","article-title":"Novel psychoactive substances: overdose of 3-fluorophenmetrazine (3-FPM) and etizolam in a 33-year-old man","volume":"2018","author":"Benesch","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.neuro.2019.02.015_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.08.032","article-title":"Proactive drugs in DFSA cases: toxicological findings in an eight-years study","volume":"291","author":"Bertol","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2019.02.015_bib0065","article-title":"Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014\u20132017","author":"Carpenter","year":"2018","journal-title":"Clin. Toxicol. Phila. (Phila)"},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hup.2222","article-title":"Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death","volume":"27","author":"Corkery","year":"2012","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuro.2019.02.015_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/dta.349","article-title":"Phenazepam and cannabinomimetics sold as herbal highs in New Zealand","volume":"4","author":"Couch","year":"2012","journal-title":"Drug Test. Anal."},{"issue":"10","key":"10.1016\/j.neuro.2019.02.015_bib0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/dta.1790","article-title":"Analysis of phenazepam and 3-hydroxyphenazepam in post-mortem fluids and tissues","volume":"7","author":"Crichton","year":"2015","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00228-012-1361-z","article-title":"First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam","volume":"69","author":"Dargan","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2016.12.020","article-title":"Mitragynine concentrations in two fatalities","volume":"271","author":"Domingo","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"1\u20133","key":"10.1016\/j.neuro.2019.02.015_bib0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.forsciint.2011.01.040","article-title":"The prevalence of drugs in injured drivers","volume":"215","author":"Drummer","year":"2012","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00414-017-1541-6","article-title":"Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer","volume":"131","author":"El Balkhi","year":"2017","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.neuro.2019.02.015_bib0105","series-title":"European Drug Report. Trends and Developments","author":"EMCDDA","year":"2016"},{"key":"10.1016\/j.neuro.2019.02.015_bib0110","series-title":"Perspective on Drugs. The Misuse of Benzodiazepines Among High-risk Opioid Users in Europe","author":"EMCDDA","year":"2018"},{"key":"10.1016\/j.neuro.2019.02.015_bib0115","series-title":"European Drug Report. Trends and Developments, 2018","author":"EMCDDA","year":"2018"},{"issue":"2","key":"10.1016\/j.neuro.2019.02.015_bib0120","first-page":"1037","article-title":"Co-occurring addition of synthetic benzodiazepine clonazolam and propylhexedrine presenting as acute brief psychosis","volume":"5","author":"Ghazi","year":"2017","journal-title":"J. Addict. Med. Ther. Sci."},{"issue":"1\u20133","key":"10.1016\/j.neuro.2019.02.015_bib0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.forsciint.2011.05.021","article-title":"Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006-2008","volume":"212","author":"Gjerde","year":"2011","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.neuro.2019.02.015_bib0130","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"issue":"6","key":"10.1016\/j.neuro.2019.02.015_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4103\/0253-7613.144943","article-title":"A case of etizolam dependence","volume":"46","author":"Gupta","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/dta.2203","article-title":"Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine","volume":"10","author":"Huppertz","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"1\u20132","key":"10.1016\/j.neuro.2019.02.015_bib0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuro.2019.02.015_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-016-0338-5","article-title":"Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipam","volume":"35","author":"Katselou","year":"2017","journal-title":"Forensic Toxicol."},{"issue":"8","key":"10.1016\/j.neuro.2019.02.015_bib0165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jat\/bkt075","article-title":"Detection of phenazepam in impaired driving","volume":"37","author":"Kerrigan","year":"2013","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.neuro.2019.02.015_bib0170","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/dta.2099","article-title":"Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism","volume":"9","author":"Kintz","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuro.2019.02.015_bib0175","first-page":"57","article-title":"Characterization of metizolam, a designer benzodiazepine, in alternative biological specimens","volume":"29","author":"Kintz","year":"2017","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.neuro.2019.02.015_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/dta.2391","article-title":"Mixed intoxication by the synthetic opioid U\u201047700 and the benzodiazepine flubromazepam with lethal outcome: pharmacokinetic data","author":"Koch","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"1\u20133","key":"10.1016\/j.neuro.2019.02.015_bib0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2012.02.006","article-title":"Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations","volume":"220","author":"Kriikku","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2019.02.015_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.forsciint.2016.02.017","article-title":"A fatal intoxication related to MDPV and pentedrone combined with antipsychotic and antidepressant substances in Cyprus","volume":"265","author":"Liveri","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2019.02.015_bib0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jflm.2015.08.017","article-title":"Phenazepam: more information coming in from the cold","volume":"36","author":"Lomas","year":"2015","journal-title":"J. Forensic Leg. Med."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","article-title":"Flubromazolam \u2013 A new life-threatening designer benzodiazepine","volume":"54","author":"\u0141ukasik-G\u0142\u0119bocka","year":"2016","journal-title":"Clin. Toxicol. Phila. (Phila)"},{"issue":"2","key":"10.1016\/j.neuro.2019.02.015_bib0205","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/dta.2349","article-title":"The emergence of new psychoactive substance (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuro.2019.02.015_bib0210","doi-asserted-by":"crossref","first-page":"d4207","DOI":"10.1136\/bmj.d4207","article-title":"Phenazepam is currently being misused in the UK","volume":"343","author":"Maskell","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.neuro.2019.02.015_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2017.04.008","article-title":"Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry","volume":"1053","author":"Meng","year":"2017","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"13","key":"10.1016\/j.neuro.2019.02.015_bib0220","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00216-016-9439-6","article-title":"Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes","volume":"408","author":"Meyer","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuro.2019.02.015_bib0225","series-title":"Benzodiazepines and Other Targeted Substances Regulations","author":"Ministry of Justice, Canada","year":"2018"},{"key":"10.1016\/j.neuro.2019.02.015_bib0230","doi-asserted-by":"crossref","DOI":"10.1007\/164_2018_154","article-title":"Designer benzodiazepines: another class of new psychoactive substances","author":"Moosmann","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuro.2019.02.015_bib0235","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jms.3279","article-title":"Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics","volume":"48","author":"Moosmann","year":"2013","journal-title":"J. Mass Spectrom."},{"issue":"7\u20138","key":"10.1016\/j.neuro.2019.02.015_bib0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/dta.1628","article-title":"Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics","volume":"6","author":"Moosmann","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"11","key":"10.1016\/j.neuro.2019.02.015_bib0245","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jms.3840","article-title":"Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam","volume":"51","author":"Moosmann","year":"2016","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.neuro.2019.02.015_bib0250","article-title":"Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising flunitrazolam, norflurazepam and 4\u2019-chlorodiazepam (Ro5-4864)","author":"Moosmann","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuro.2019.02.015_bib0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpba.2018.02.032","article-title":"In vitro Phase I and Phase II metabolism of the new designer benzodiazepine cloniprazepam using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry","volume":"153","author":"Mortel\u00e9","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.neuro.2019.02.015_bib0260","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/dta.2146","article-title":"In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples","volume":"9","author":"Noble","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O\u2019Connell","year":"2015","journal-title":"Ann. Emerg. Med."},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"9","key":"10.1016\/j.neuro.2019.02.015_bib0275","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jat\/bky039","article-title":"A case study involving U-47700, diclazepam and flubromazepam\u2013application of retrospective analysis of HRMS data","volume":"42","author":"Partridge","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","article-title":"Development and application of a multi-component LC-MS\/MS method for determination of designer benzodiazepines in urine","volume":"1035","author":"Pettersson Bergstrand","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0285","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson Bergstrand","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0290","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/dta.2243","article-title":"Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry","volume":"10","author":"Pettersson Bergstrand","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dta.2463","article-title":"In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases","volume":"11","author":"Pettersson Bergstrand","year":"2019","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0300","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1373\/jalm.2017.025387","article-title":"Novel benzodiazepines (clonazolam and flubromazolam) identified in candy-like pills","volume":"3","author":"Pope","year":"2018","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.neuro.2019.02.015_bib0305","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.forsciint.2015.07.033","article-title":"Phenazepam: a review of medico-legal deaths in South Scotland between 2010 and 2014","volume":"254","author":"Shearer","year":"2015","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jat\/bks080","article-title":"Phenazepam and its effects on driving","volume":"37","author":"Stephenson","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2019.02.015_bib0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.talanta.2017.08.010","article-title":"Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis - Tandem mass spectrometry with successive multiple ionic - Polymer layer coated capillary","volume":"176","author":"\u0160vidrnoch","year":"2018","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.neuro.2019.02.015_bib0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0325","first-page":"38","article-title":"An autopsy case of multiple psychotropic drug poisoning","volume":"56","author":"Tanaka","year":"2011","journal-title":"Soud. Lek."},{"issue":"1","key":"10.1016\/j.neuro.2019.02.015_bib0330","first-page":"5","article-title":"A case of drowning whilst under the influence of brotizolam, flunitrazepam and ethanol","volume":"56","author":"Tanaka","year":"2011","journal-title":"Soud. Lek."},{"key":"10.1016\/j.neuro.2019.02.015_bib0335","unstructured":"TripSit FactSheets, http:\/\/drugs.tripsit.me. Accessed 11 October 2018."},{"key":"10.1016\/j.neuro.2019.02.015_bib0340","series-title":"Non-medical Use of Benzodiazepines: a Growing Threat to Public Health? Global Smart Update","first-page":"18","author":"UNODC","year":"2017"},{"key":"10.1016\/j.neuro.2019.02.015_bib0345","series-title":"The Challenge of Synthetic Drugs in East and South-East Asia. Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances","author":"UNODC","year":"2017"},{"key":"10.1016\/j.neuro.2019.02.015_bib0350","series-title":"April 2017 \u2013 UNODC: Several Countries Place Benzodiazepine Derivatives Under National Control","author":"UNODC","year":"2017"},{"key":"10.1016\/j.neuro.2019.02.015_bib0355","series-title":"June 2018 \u2013 Scotland: Number of Deaths Involving Benzodiazepine-type NPS Etizolam and Diclazepam Increase Sharply in 2016","author":"UNODC","year":"2018"},{"key":"10.1016\/j.neuro.2019.02.015_bib0360","first-page":"94","article-title":"Blotter acid mimic (actually containing phenazepam) in North Carolina","volume":"42","author":"US Department of Justice Drug Enforcement Administration","year":"2009","journal-title":"Microgram Bulletin"},{"key":"10.1016\/j.neuro.2019.02.015_bib0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.forsciint.2017.09.010","article-title":"Toxicological findings in suspected drug-impaired drivers in Norway - Trends during 1990-2015","volume":"280","author":"Valen","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1208\/s12248-016-0040-x","article-title":"Identifying metabolites of meclonazepam by high-resolution mass spectrometry using human liver microsomes, hepatocytes, a mouse model, and authentic urine samples","volume":"19","author":"Vikingsson","year":"2017","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.neuro.2019.02.015_bib0375","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2003.019869","article-title":"Etizolam and benzodiazepine induced blepharospasm","volume":"75","author":"Wakakura","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neuro.2019.02.015_bib0380","series-title":"Phenazepam. Pre-review Report. Agenda Item 5.8. Expert Committee on Drug Dependence Thirty-seventh Meeting","author":"WHO","year":"2015"},{"key":"10.1016\/j.neuro.2019.02.015_bib0385","unstructured":"WHO, 2017. ETIZOLAM Critical Review Report. Agenda Item 4.13. Expert Committee on Drug DependenceThirty-ninth Meeting Geneva, 6-10 November. 2017. http:\/\/www.who.int\/medicines\/access\/controlled-substances\/CriticalReview_Etizolam.pdf."},{"key":"10.1016\/j.neuro.2019.02.015_bib0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2016.10.021","article-title":"Looking at flubromazolam metabolism from four different angles: metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry","volume":"274","author":"Wohlfarth","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuro.2019.02.015_bib0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jflm.2015.09.009","article-title":"Review: drug concentrations in hair and their relevance in drug facilitated crimes","volume":"36","author":"Xiang","year":"2015","journal-title":"J. Forensic Leg. Med."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X19300178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X19300178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:17:44Z","timestamp":1758982664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X19300178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":79,"alternative-id":["S0161813X19300178"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2019.02.015","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An expanding world of new psychoactive substances\u2014designer benzodiazepines","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2019.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}